Cysteine

Bruton agammaglobulinemia tyrosine kinase ; Mus musculus







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34662393 Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia. 2022 Feb 10 2
2 32492159 Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects. 2020 Jun 9 2